Margaret Wagner, PA
Physician Assistant · Indianapolis, INNPI 1437878055
Payments from drug & device makers
Across 231 payments — averaging $16.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$658
- AstraZeneca$544
- Novo Nordisk$492
- Lilly USA, LLC$348
- Corcept Therapeutics$306
- Amgen$151
- plus $1K from 29 others
What the payments were for
- Food & beverage$3,74299%
- Education$291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $658 |
| AstraZeneca(2 entities) | 21 | $544 |
| Novo Nordisk | 41 | $492 |
| Lilly USA, LLC | 23 | $348 |
| Corcept Therapeutics | 20 | $306 |
| Amgen | 6 | $151 |
| Bayer | 8 | $148 |
| Pfizer | 7 | $126 |
| GSK | 8 | $117 |
| Shield Therapeutics Inc | 5 | $87 |
| Antares Pharma, Inc. | 5 | $80 |
| Astellas Pharma US Inc | 4 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Halozyme Inc | 3 | $53 |
| Exact Sciences | 2 | $44 |
| Idorsia Pharmaceuticals US Inc | 3 | $43 |
| Edwards Lifesciences | 1 | $41 |
| Novartis | 2 | $39 |
| Si-bone, Inc. | 1 | $34 |
| Paratek Pharmaceuticals, Inc. | 2 | $32 |
| Boehringer Ingelheim | 2 | $31 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Currax Pharmaceuticals LLC | 2 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
| Sanofi Pasteur Inc. | 1 | $27 |
| Esperion Therapeutics, Inc. | 1 | $26 |
| Nestle Healthcare Nutrition Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $22 |
| Insulet Corporation | 1 | $18 |
| Merck | 1 | $15 |
| IBSA Pharma Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,771 in reported general payments places this provider in the 90th percentile of 1,955 physician assistant providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 44 | $61,284 |
| MounjaroTirzepatide | 50 | $48,736 |
| JardianceEmpagliflozin | 19 | $28,620 |
| EliquisApixaban | 15 | $24,821 |
| TrulicityDulaglutide | 12 | $15,851 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $7,037 |
| Memantine Hcl ErMemantine Hcl | 13 | $3,962 |
| Losartan Potassium | 156 | $1,594 |
| Levothyroxine Sodium | 173 | $1,579 |
| Omeprazole | 97 | $1,418 |
| Metoprolol Succinate | 122 | $1,360 |
| Rosuvastatin Calcium | 107 | $1,296 |
| Atorvastatin Calcium | 224 | $1,264 |
| Amlodipine Besylate | 152 | $959 |
| Gabapentin | 61 | $850 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $348 | $64,58762 claims |
| Novo NordiskOzempic | $492 | $61,28444 claims |
| Boehringer IngelheimJardiance | $31 | $28,62019 claims |
| PfizerEliquis | $126 | $24,82115 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $14 | $1,579173 claims |
| AbbVieSynthroid | $658 | $75116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,955 physician assistant providers in Indiana.
Other physician assistant in Indianapolis
- Andrew NordIndianapolis$47K
- Qun Ming ZhangIndianapolis$28K
- Lindsay YoderIndianapolis$21K
- Mackenzie LawsonIndianapolis$15K
- Christina RaceIndianapolis$13K
- Zara BogenschutzIndianapolis$12K
- Ashley WorthingtonIndianapolis$11K
- Madison MaloofIndianapolis$10K
- Jason BrownIndianapolis$10K
- Michaela WehrIndianapolis$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.